Windtree Therapeutics, Inc. (WINT) Balance Sheet
WINT balance sheet, 2024
December 31, 2024 · U.S. dollars$27.9M assets = $17.9M liabilities + $10.0M equity
Both columns are drawn to the same scale: what WINT owns equals what it owes plus shareholders’ equity. Hover a block for its value.
WINT financial health
Descriptive bands, not a rating. Fiscal 2024.
WINT balance sheet trends, 2015–2024
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $44.4M2015 | $27.9M2024 | −5.0%/yr | |
| Total liabilities | $36.1M2015 | $17.9M2024 | −7.5%/yr | |
| Shareholders’ equity | $8.3M2015 | $10.0M2024 | +2.1%/yr | |
| Cash & short-term investments | $38.7M2015 | $1.8M2024 | −29.0%/yr | |
| Total debt | $25.2M2015 | $1.8M2024 | −25.3%/yr | |
| Net cash (debt) | $13.5M2015 | −$43,0002024 | −$13.5M | |
| Working capital | $29.7M2015 | −$3.1M2024 | −$32.9M | |
| Current ratio | 3.692015 | 0.452024 | −3.24 | |
| Debt / equity | 3.052015 | 0.182024 | −2.87 |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
WINT assets
WINT liabilities and equity
WINT debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
WINT balance sheet
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & short-term investments | $1.8M | $4.3M | $6.2M | $22.3M | $16.9M | $22.6M | $25.1M | $1.8M | $5.6M | $38.7M |
| Cash & equivalents | $1.8M | $4.3M | $6.2M | $22.3M | $16.9M | $22.6M | $11.2M | $1.8M | $5.6M | $38.7M |
| Short-term investments | — | — | — | — | — | $0 | $14.0M | — | — | — |
| Receivables | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other current assets | $795,000 | $1.1M | $1.2M | $1.1M | $1.2M | $1.3M | $507,000 | $422,000 | $1.6M | $2.1M |
| Total current assets | $2.6M | $5.4M | $7.4M | $23.5M | $18.1M | $23.9M | $25.7M | $2.2M | $7.2M | $40.8M |
| Property, plant & equipment (net) | $1.2M | $1.6M | $2.1M | $3.4M | $1.8M | $2.2M | $802,000 | $885,000 | $1.1M | $1.0M |
| Goodwill & intangible assets | $24.1M | $25.2M | $28.3M | $47.8M | $92.8M | $92.8M | $92.8M | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $9,000 | $150,000 | $154,000 | $154,000 | $154,000 | $154,000 | $171,000 | $225,000 | $1.5M | $2.5M |
| Total assets | $27.9M | $32.4M | $38.0M | $74.8M | $112.9M | $119.0M | $119.4M | $3.3M | $9.7M | $44.4M |
| Liabilities | ||||||||||
| Accounts payable | $1.9M | $809,000 | $249,000 | $693,000 | $1.2M | $1.7M | $3.4M | $3.0M | $1.8M | $3.3M |
| Short-term debt | $1.2M | $669,000 | $656,000 | $822,000 | $1.2M | $911,000 | $8.0M | $15.0M | $25.0M | $223,000 |
| Deferred revenue | — | — | — | — | — | — | $198,000 | $884,000 | — | — |
| Total current liabilities | $5.7M | $4.0M | $2.5M | $4.9M | $6.1M | $7.8M | $20.6M | $11.8M | $13.4M | $11.1M |
| Long-term debt | $0 | $0 | $0 | $0 | $2.4M | $19.6M | $15.0M | $15.0M | $25.0M | $25.0M |
| Lease obligations | $1.2M | $1.6M | $2.0M | $2.6M | $1.0M | $1.5M | — | — | — | — |
| Other long-term liabilities | $12.2M | $25.0M | $25.5M | $28.0M | $34.8M | $16.6M | $15.7M | $507,000 | $138,000 | $43,000 |
| Total liabilities | $17.9M | $29.0M | $27.9M | $32.9M | $43.3M | $44.0M | $51.3M | $27.3M | $38.5M | $36.1M |
| Shareholders' equity | ||||||||||
| Common stock & paid-in capital | $305,000 | $6,000 | — | $28,000 | $17,000 | $41,000 | $32,000 | $3,000 | $9,000 | $8,000 |
| Retained earnings (deficit) | −$846.6M | −$844.8M | −$824.5M | −$785.3M | −$717.7M | −$685.1M | −$657.6M | −$637.1M | −$618.7M | −$579.2M |
| Treasury stock | — | — | — | — | −$3.1M | −$3.1M | −$3.1M | −$3.1M | −$3.1M | −$3.1M |
| Accumulated other comprehensive income | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | −$7.0M | −$8.5M |
| Total shareholders' equity | $10.0M | $3.4M | $10.0M | $41.9M | $69.6M | $74.9M | $68.1M | −$23.9M | −$28.8M | $8.3M |
| Key figures | ||||||||||
| Total debt | $1.8M | $16.8M | $2.3M | $2.9M | $3.8M | $20.5M | $23.0M | $15.0M | $25.0M | $25.2M |
| Net cash (debt) | −$43,000 | −$12.5M | $3.9M | $19.5M | $13.1M | $2.1M | $2.2M | −$13.2M | −$19.4M | $13.5M |
| Working capital | −$3.1M | $1.4M | $4.9M | $18.6M | $12.0M | $16.0M | $5.0M | −$9.5M | −$6.2M | $29.7M |
| Tangible book value | −$14.1M | −$21.9M | −$18.3M | −$5.9M | −$23.2M | −$17.8M | −$24.7M | −$23.9M | −$28.8M | $8.3M |
| Current ratio | 0.45 | 1.35 | 3.00 | 4.77 | 2.96 | 3.05 | 1.24 | 0.19 | 0.54 | 3.69 |
| Quick ratio | 0.31 | 1.08 | 2.51 | 4.54 | 2.76 | 2.89 | 1.22 | 0.15 | 0.42 | 3.50 |
| Debt / equity | 0.18 | 4.96 | 0.23 | 0.07 | 0.05 | 0.27 | 0.34 | — | — | 3.05 |
| Equity / assets | 35.9% | 10.5% | 26.4% | 56.0% | 61.6% | 63.0% | 57.0% | −714.7% | −297.2% | 18.6% |
| Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | Jun '23 | Mar '23 | Dec '22 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $204,000 | $301,000 | $1.2M | $1.8M | $2.3M | $1.8M | $2.5M | $4.3M | $7.4M | $11.5M | $4.2M | $6.2M |
| Cash & equivalents | $204,000 | $301,000 | $1.2M | $1.8M | $2.3M | $1.8M | $2.5M | $4.3M | $7.4M | $11.5M | $4.2M | $6.2M |
| Receivables | $5.8M | $4.8M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other current assets | $1.2M | $1.7M | $421,000 | $795,000 | $1.6M | $256,000 | $792,000 | $1.1M | $1.5M | $1.9M | $987,000 | $1.2M |
| Total current assets | $7.2M | $6.8M | $1.6M | $2.6M | $3.9M | $2.1M | $3.3M | $5.4M | $8.9M | $13.3M | $5.2M | $7.4M |
| Property, plant & equipment (net) | $768,000 | $901,000 | $1.0M | $1.2M | $1.3M | $1.4M | $1.5M | $1.6M | $1.7M | $1.9M | $2.0M | $2.1M |
| Goodwill & intangible assets | $8.0M | $24.1M | $24.1M | $24.1M | $25.2M | $25.2M | $25.2M | $25.2M | $25.2M | $25.2M | $27.8M | $28.3M |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $10,000 | $10,000 | $9,000 | $9,000 | $9,000 | $9,000 | $9,000 | $150,000 | $150,000 | $150,000 | $163,000 | $154,000 |
| Total assets | $16.0M | $31.8M | $26.8M | $27.9M | $30.4M | $28.7M | $30.1M | $32.4M | $36.1M | $40.6M | $35.2M | $38.0M |
| Liabilities | ||||||||||||
| Accounts payable | $1.7M | $4.1M | $3.1M | $1.9M | $2.1M | $3.0M | $1.7M | $809,000 | $944,000 | $964,000 | $753,000 | $249,000 |
| Short-term debt | $12.7M | $8.3M | $1.1M | — | $1.2M | $2.5M | $446,000 | $669,000 | $906,000 | $1.1M | $389,000 | $656,000 |
| Deferred revenue | — | — | — | — | — | — | — | — | −$467,000 | −$700,000 | — | — |
| Total current liabilities | $21.9M | $15.7M | $6.5M | $5.7M | $14.4M | $8.8M | $5.0M | $4.0M | $3.7M | $3.8M | $2.8M | $2.5M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Lease obligations | $784,000 | $912,000 | $1.0M | $1.2M | $1.3M | $1.4M | $1.5M | $1.6M | $1.7M | $1.8M | $1.9M | $2.0M |
| Other long-term liabilities | $5.7M | $12.5M | $10.0M | $12.2M | $11.6M | $16.4M | $9.7M | $25.0M | $24.9M | $25.2M | $25.4M | $25.5M |
| Total liabilities | $27.6M | $28.2M | $16.5M | $17.9M | $26.0M | $25.2M | $14.7M | $29.0M | $28.6M | $29.0M | $28.2M | $27.9M |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | $34,000 | $9,000 | $4,000 | — | $2,000 | $1,000 | $1,000 | $6,000 | $5,000 | $5,000 | $1,000 | — |
| Retained earnings (deficit) | −$889.4M | −$861.3M | −$850.7M | −$846.6M | −$848.8M | −$846.6M | −$834.6M | −$844.8M | −$839.7M | −$835.2M | −$828.6M | −$824.5M |
| Accumulated other comprehensive income | — | — | $0 | — | — | −$7.0M | $0 | $0 | $0 | $0 | $0 | $0 |
| Total shareholders' equity | −$11.6M | $3.6M | $10.3M | $10.0M | $4.4M | $3.5M | $15.4M | $3.4M | $7.5M | $11.6M | $7.0M | $10.0M |
| Key figures | ||||||||||||
| Total debt | $12.9M | $8.7M | $1.6M | — | $2.0M | $3.4M | $1.5M | $1.8M | $17.2M | $2.5M | $1.9M | $2.3M |
| Net cash (debt) | −$12.7M | −$8.4M | −$406,000 | — | $287,000 | −$1.6M | $1.1M | $2.5M | −$9.8M | $9.0M | $2.3M | $3.9M |
| Working capital | −$14.7M | −$8.9M | −$4.9M | −$3.1M | −$10.5M | −$6.7M | −$1.6M | $1.4M | $5.2M | $9.5M | $2.5M | $4.9M |
| Tangible book value | −$19.6M | −$20.5M | −$13.8M | −$14.1M | −$20.8M | −$21.8M | −$9.8M | −$21.9M | −$17.8M | −$13.6M | −$20.8M | −$18.3M |
| Current ratio | 0.33 | 0.43 | 0.25 | 0.45 | 0.27 | 0.23 | 0.67 | 1.35 | 2.40 | 3.51 | 1.89 | 3.00 |
| Quick ratio | 0.27 | 0.33 | 0.18 | 0.31 | 0.16 | 0.21 | 0.51 | 1.08 | 1.99 | 3.02 | 1.53 | 2.51 |
| Debt / equity | — | 2.41 | 0.15 | — | 0.46 | 0.97 | 0.10 | 0.54 | 2.29 | 0.22 | 0.27 | 0.23 |
| Equity / assets | −72.6% | 11.3% | 38.4% | 35.9% | 14.5% | 12.2% | 51.2% | 10.5% | 20.8% | 28.6% | 20.0% | 26.4% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed April 15, 2025); data from EODHD.
WINT financial position
At the end of fiscal 2024 (December 31, 2024), Windtree Therapeutics had total assets of $27.9 million (down 14.0% from a year earlier), total liabilities of $17.9 million and shareholders' equity of $10.0 million. It held $1.8 million in cash and short-term investments against $1.8 million of debt, net debt of $0.0 million. Its current ratio was 0.45. In the latest quarter (ended September 30, 2025) total assets were $16.0 million and equity -$11.6 million.
Related: WINT income statement, WINT cash flow statement, WINT key metrics. See the WINT stock overview for the latest quote and news.
WINT balance sheet FAQ
What are Windtree Therapeutics's total assets?
Windtree Therapeutics reported total assets of $27.9 million at the end of fiscal 2024 (December 31, 2024), compared with $32.4 million a year earlier.
How much debt does Windtree Therapeutics have?
Windtree Therapeutics had $1.8 million of total debt at the end of fiscal 2024, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 0.18.
How much cash does Windtree Therapeutics have?
Windtree Therapeutics held $1.8 million in cash and short-term investments at the end of fiscal 2024; with $1.8 million of debt that is net debt of $0.0 million.
What is Windtree Therapeutics's book value?
Windtree Therapeutics's shareholders' equity (book value) was $10.0 million at the end of fiscal 2024.
What is Windtree Therapeutics's current ratio?
Windtree Therapeutics had current assets of $2.6 million and current liabilities of $5.7 million, a current ratio of 0.45 (current liabilities exceed current assets).
How much goodwill does Windtree Therapeutics have?
Windtree Therapeutics carried $24.1 million of goodwill and intangible assets, 86.6% of total assets, at the end of fiscal 2024.